GPhC reveals draft criteria to cut record number of fitness-to-practise concerns The General Pharmaceutical Council said that concerns raised have doubled over the past five years, from 2,989 in 2020/2021 to 6,202 in 2024/2025.…
Investigations ongoing as regulator takes action against Jhoots The General Pharmaceutical Council's enforcement action against Jhoots follows concerns raised about unexpected closures and ‘poor service’ in several branches.…
GPhC warns of emerging patient safety issues In a letter to pharmacists, pharmacy technicians and pharmacy owners, Roz Gittins has highlighted concerns reported to the regulator and the importance of ensuring safe and effective pharmacy care for patients.…
GPhC chief executive to step down after 15 years in post Duncan Rudkin has served as chief executive of the General Pharmaceutical Council since the regulator was established in 2010.…
GPhC registration assessment pass mark reaches 77% The delayed data for the summer 2025 exam also reveal that first-time candidates achieved a pass rate of 80%.…
Pharmacy trainees unable to access GPhC exam results Regulator issues apology after glitch stops foundation-year trainees from getting their registration assessment results.…
NPA warns of ‘spiralling demand’ for NHS weight-loss medications Survey results revealed that nearly one-quarter of UK adults tried to access weight-loss treatments in the past year via pharmacies.…
Regulator plans policy overhaul on disqualification powers The General Pharmaceutical Council said it will close disqualification cases against pharmacy owners that are no longer in the public interest and pose no risk to the public.…
GPhC confirms 6% fee rise following consultation The regulator said that the decision to raise its annual registration fees was influenced by increased operational costs and a need to ensure that it effectively carries out its regulatory responsibilities.…
Regulator to trial independent complaint handling service as fitness-to-practise reports reach ‘record high’ The General Pharmaceutical Council says that concerns reported to the regulator have increased by 13% year on year and by more than 100% over the past four years.…
